One Health as a holistic approach to combating antibiotic resistance

Prof. Katharina Schaufler, PhD, Head of the Department “Epidemiology and Ecology of Antimicrobial Resistance” at HIOH

Shownotes

At the Helmholtz Centre for Infection Research, scientists investigate the mechanisms of infectious diseases and their defenses. We systematically develop the results of basic research towards medical applications. The scientific questions we work on include:

  • What turns bacteria or viruses into pathogens?
  • Why are some people particularly susceptible and others resistant to infections?
  • How can we intervene in infection processes?
  • How do we transfer our findings to application in humans?

To clarify such questions, we are investigating pathogens that are medically relevant or that can be used as models for research into infections. Understanding these mechanisms will contribute to combating infectious diseases with new drugs and vaccines.

Aims

The Centre's mission is to contribute to overcoming the challenges that infectious diseases pose to medicine and society in the 21st century. The HZI has defined its research priorities in the Infection Research Program. The program places particular emphasis on the transfer of research results into application, on individualized infection medicine and the application of information and data technologies for infection research.

If you would like to find out more about the HZI, take a look at www.helmholtz-hzi.de/en!

Transkript anzeigen

00:00:03: A refreshing swim in a lake or the sea.

00:00:06: And a few days later, a life-threatening infection

00:00:09: that antibiotics struggle to treat.

00:00:14: It's a frightening scenario that highlights

00:00:16: the growing threat of antibiotic resistance.

00:00:19: In this episode of InFact, host Julia Demann speaks to Professor

00:00:24: Katharina Schaufler, a microbiologist and veterinarian

00:00:27: who leads a research group on antimicrobial resistance

00:00:30: at the Helmholtz Institute for One Health in Greifswald.

00:00:34: Schaufler explains how resistant

00:00:36: bacteria connect human health, animals and the environment,

00:00:40: and why reducing antibiotic use in people is only part of the solution.

00:00:44: She also discusses why awareness should start in childhood.

00:00:48: What makes antibiotic resistance a so-called silent pandemic

00:00:52: and what we can do to address it?

00:00:56: Hi, Katharina.

00:00:57: Nice to have you here. Hi, Julia.

00:00:59: Thank you for having me here. I'm very excited.

00:01:01: Katharina, you're involved in so many things.

00:01:04: But today we are focusing primarily on your research

00:01:07: and public outreach regarding antibiotic resistance.

00:01:10: And we've talked about this topic several times

00:01:13: on this podcast, especially in connection with hospital-acquired infections.

00:01:17: But you're also studying is occurrence in animals and yeah, in our environment.

00:01:22: Why is that so important?

00:01:24: It's so important to look into the AMR distribution.

00:01:28: So AMR means antimicrobial resistance because

00:01:32: we do not only have AMR in humans and in the medical health care setting,

00:01:36: but also in animals and in the environment.

00:01:39: And it's all connected.

00:01:41: All the compartments are connected.

00:01:43: And this is why we look into it from this overall perspective.

00:01:48: In line with your research, the topic of this year's World

00:01:53: Antibiotic Awareness Week is One

00:01:56: Health, One Action Prevent AMR.

00:01:59: Now how does this increase attention may help your research.

00:02:04: It's so important for the community also to be involved, because we just need

00:02:10: to talk about AMR as a whole population and the whole humanity basically.

00:02:17: And the more we talk about AMR and also during the awareness week, the better.

00:02:22: That makes it easier for our research for different research groups.

00:02:26: And also, as I said, for the community itself and also

00:02:29: for the different kind of stakeholders.

00:02:32: What does the One Health approach look like in the fight

00:02:36: against antibiotic resistance?

00:02:38: Can you tell me a bit more?

00:02:39: Maybe it's absolutely important to fight AMR holistically

00:02:45: and within the One Health context, because AMR doesn't know any borders.

00:02:50: It can be transmitted between humans and animals, and also

00:02:55: the environment can be a reservoir of AMR and for AMR and vice versa, obviously.

00:03:01: So it is not enough to look into one sector separately,

00:03:06: but we have to connect the dots in the different compartments

00:03:09: to really fight the silent pandemic.

00:03:11: Yeah, you mentioned

00:03:11: silent pandemic, but for our listeners, if you want to learn more about

00:03:16: antimicrobial resistance, please listen to episode two of our podcast.

00:03:21: Now back to you, Katharina.

00:03:23: Where do you look for resistant bacteria?

00:03:26: Which habitats and animals are you investigating?

00:03:29: We're looking into different compartments.

00:03:32: So like in animals, obviously, but also in humans from the clinic

00:03:37: and the environment.

00:03:38: So we're located in Greifswald, which is near to the Baltic Sea.

00:03:42: So for instance, what we're doing

00:03:43: is that we're tracking AMR pathogens from the wastewater

00:03:48: treatment plant to the Bodden, which is a part of the Baltic Sea.

00:03:53: And we have found AMR bacteria there, and also in wild birds

00:03:57: in the region that use those border sources to feed on and to like.

00:04:02: Yeah, just like breed in etc.

00:04:05: So it's all connected.

00:04:06: And this is why we also look in these different kinds of compartments.

00:04:11: When I hear water bodies where I can swim, I love

00:04:15: swimming in the sea also in the Bodden.

00:04:17: See, I'm a little bit worried because, yeah, of the

00:04:21: resistant bacteria in these water bodies dangerous to swimmers.

00:04:25: Can can you say a bit more about this?

00:04:27: Please don't panic.

00:04:28: You're still allowed to swim in the Baltic Sea and then other water bodies.

00:04:33: It's more like an issue for people

00:04:36: with an immunocompromised system

00:04:39: or big surface wounds.

00:04:42: There is the potential of such resistant bacteria

00:04:46: to to enter the system and the body, and to cause an infection

00:04:50: or like a surface infection is being caused.

00:04:53: But in general, we find antibiotic- resistant bacteria in a lot of places,

00:04:58: and a lot of times they don't make a primary problem.

00:05:02: But if you find a resistant bacteria somewhere,

00:05:06: what exactly do you investigate?

00:05:08: We look first:

00:05:09: What kind of AMR bacterium do we have?

00:05:12: What kind of characteristics does it have?

00:05:15: Is it closely related to those that come from the clinic,

00:05:18: and that make a problem in the clinics or in animals, for instance?

00:05:22: We also look into the distribution of particular resistances.

00:05:26: Is it, in theory still treatable with antibiotics, for instance?

00:05:30: And what we also look into is into like how dangerous is it really?

00:05:36: Like, does it have the possibility and the capability

00:05:40: better to cause infection or not?

00:05:43: You already said it.

00:05:44: Antibiotic resistance

00:05:46: seems to be practically everywhere and you already called it silent pandemic.

00:05:50: What does this actually mean?

00:05:52: The silent pandemic consists of two words the silence and the pandemic.

00:05:57: When we hear pandemic, we instantly think of the COVID-19 pandemic, for instance.

00:06:03: Yeah, silence in this context means

00:06:06: that we cannot really,

00:06:09: yeah, see it on a daily basis, I would say.

00:06:13: So those bacteria that are resistant.

00:06:16: Yeah.

00:06:17: Maybe you have heard of them from from somebody

00:06:20: needing to go to the hospital or something like that, or

00:06:24: maybe from the media, but in general for the

00:06:27: majority at this point still.

00:06:31: Yeah.

00:06:31: It's not really there or present or something happening.

00:06:35: So it's not so acute.

00:06:37: It's a slow pandemic, it's silent, it kind of goes under the radar.

00:06:42: But nevertheless it is a pandemic.

00:06:45: We have those AMR bacteria all over the world.

00:06:48: Different regions are affected.

00:06:50: And this is why we still have to call it a pandemic,

00:06:53: but it's less pressuring, I would say.

00:06:57: And where do you focus your research in this area?

00:07:02: We have three different research approaches at the moment in my group.

00:07:06: The first one is to understand what kind of AMR

00:07:11: bacteria occur, where in the three different compartments,

00:07:15: and humans, animals and the environment and how they're being transmitted.

00:07:20: The second approach is to really understand

00:07:22: what kind of characteristics they have, what kind of resistances, but also

00:07:27: what kind of virulence genes or features that makes them infectious and dangerous.

00:07:32: And the third thing is then to really focus on alternative strategies

00:07:37: to fight AMR bacteria based on

00:07:40: what we know about where they occur

00:07:43: and what they consist of and how they're made up.

00:07:48: And what are these strategies.

00:07:50: Maybe you can tell a bit more about this.

00:07:52: So those are alternative strategies to disarm pathogens.

00:07:56: We don't want to make them less resistant.

00:07:58: We're also not developing novel antibiotics.

00:08:01: We look into making specifically successful

00:08:06: AMR pathogens less dangerous so that the immune system

00:08:10: or conventional antibiotics can be used again to treat them.

00:08:15: And this is already done in the clinic.

00:08:17: Or is this your goal to to do this in the clinic?

00:08:22: This is something that we're working on in already.

00:08:25: And there are examples already commercially available,

00:08:29: not developed by us.

00:08:30: Obviously, when you think of like

00:08:33: substances that you can take in urinary tract infections

00:08:36: that kind of hinder bacteria to attach to

00:08:39: to to the bladder epithelial wall.

00:08:42: Yeah, I know this.

00:08:42: But yeah, we're we're working towards that as well.

00:08:47: Like with similar strategies I would say

00:08:51: Nice.

00:08:51: So it's kind of physical

00:08:54: not just not genetically editing or something like this.

00:08:59: Yeah. Okay.

00:09:00: I understood that in addition to all your research project,

00:09:03: you're also involved in science communication, as we do

00:09:07: now, but not just for adults, also for children.

00:09:11: What exactly do you do there?

00:09:13: For example, we have a project where we got together together

00:09:17: with school kits to collect flies to look for AMR bacteria in and on flies.

00:09:22: So this is there like involved from the start, from the beginning,

00:09:26: like starting from collecting over like an analysing and evaluating the results.

00:09:32: And we just started a project where we kind of establish

00:09:37: a learning route with boards on the Baltic Sea

00:09:42: for especially younger kids to understand what AMR

00:09:46: actually means, what it means when we find it in the environment,

00:09:50: whether it's bad or not, and what everybody can do to

00:09:54: to actually avoid an infection with AMR pathogens.

00:09:59: Why do you think it's so important to do this with children?

00:10:03: And also how does this help your research?

00:10:07: I think it's super important to start as young as you can

00:10:10: and as young as possible, because only when you know

00:10:14: of the threat and the danger, you can do something about it.

00:10:18: And for especially the silent pandemic of antimicrobial resistance,

00:10:23: it's important that everybody works together and knows what it means

00:10:28: and what everyone can do on a daily basis to avoid transmission

00:10:33: of AMR bacteria or in general, emergence of AMR.

00:10:37: So yeah, start with the youngest.

00:10:40: That's that's the best.

00:10:41: How does this help your research?

00:10:44: Well it is it helps our research because we get kind of views from from the kids.

00:10:50: Sometimes they ask questions that you would have never thought

00:10:53: of before from like a very scientific standpoint.

00:10:56: So it's it's really cool and interesting to see how kids think about the problem

00:11:02: and maybe with what kind of interests they come up with or

00:11:06: in which kind of habitats, for instance, they want to look for AMR.

00:11:09: That's also what we've learned in the past,

00:11:11: that they had interesting ideas of where to sample, actually,

00:11:15: and we had interesting results from from that.

00:11:18: So it's super interesting

00:11:20: to kind of get a different perspective on the overall topic as well.

00:11:25: What would you do in your research,

00:11:27: for example, if costs were no object from a

00:11:32: daily perspective, I would say

00:11:34: it's like it happens a lot to us, that we have a lot of findings in a lab

00:11:40: where we don't have the capacities at the moment to just follow up on them,

00:11:44: and if costs won't play a role, and I wouldn't be busy myself

00:11:49: the whole day writing grants or publications and stuff like that,

00:11:53: I would probably, first of all, go back to the lab myself

00:11:57: to some wet lab work because I wouldn't have to write so many grants

00:12:01: and just like follow up on the cool little things that that just pop up,

00:12:07: day, day to day and that we, as I said,

00:12:12: don't have the time to kind of follow up on on a regular basis.

00:12:16: I can imagine as I, yeah, sometimes miss the lab as a biologist.

00:12:22: Yeah, but no, I'm a science journalist.

00:12:24: It's also very cool.

00:12:25: And when.

00:12:27: Well, I think you do a lot of research and you have the science communication

00:12:32: that you do, but how do you balance

00:12:36: your, your work, your work in your free time?

00:12:39: And yeah, what do you do there as a scientist?

00:12:43: You kind of are never really 100% off work sometimes I would say,

00:12:49: because, yeah, thoughts are just coming in and you think about different science

00:12:53: problems or challenges the whole time, at least in my case.

00:12:58: But I kind of combine.

00:13:00: Yeah, those kind of loosely thinking

00:13:03: and popping up ideas in nature.

00:13:07: So I like to spend time outside with my horse.

00:13:12: And this is the time where new ideas arise, but also where I can just like,

00:13:19: you know, let my mind flow and think about other things and really like

00:13:22: settle, settle down a little bit and get a little calm.

00:13:27: I can imagine.

00:13:29: And last question if you have like

00:13:32: a take-home message to our listeners,

00:13:35: what can we all do to avoid

00:13:39: or maybe to combat the spread of antibiotic resistance?

00:13:44: AMR and fighting AMR specifically is a unifying

00:13:50: task, and everybody can do something against that.

00:13:54: Starting from hygiene, hand hygiene, over

00:13:57: taking your antibiotics exactly as prescribed.

00:14:01: Over.

00:14:02: Yeah, different other things like don't throw out antibiotics

00:14:06: basically in the toilet.

00:14:09: So yeah, AMR is important in the One Health approach and context,

00:14:15: but also as like one human population

00:14:20: and only together we can fight the threat.

00:14:23: That's my yeah I'm convinced about that.

00:14:26: Thanks a lot, Katharina, for the interesting information and your time.

00:14:30: Thank you.

00:14:31: Katharina Schaufler is researching antimicrobial resistance, is looking

00:14:35: especially on the One

00:14:37: Health approach at the Helmholtz Institute for One Health in Greifswald.

00:14:41: And we hear each other in the next Episode, bye.

Neuer Kommentar

Dein Name oder Pseudonym (wird öffentlich angezeigt)
Mindestens 10 Zeichen
Durch das Abschicken des Formulars stimmst du zu, dass der Wert unter "Name oder Pseudonym" gespeichert wird und öffentlich angezeigt werden kann. Wir speichern keine IP-Adressen oder andere personenbezogene Daten. Die Nutzung deines echten Namens ist freiwillig.